UTHR logo

United Therapeutics (UTHR)

Profile

Full Name

United Therapeutics Corporation

Ticker Symbol

UTHR

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

June 17, 1999

Indexes

Not included

Website

http://www.unither.com

Employees

1305

Key Details

Price

$281.16(+0.81%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.88B(+23.63% YoY)

Annual EPS

$24.64(+24.38% YoY)

PE ratio

11.43

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$281.16
UTHR price is $281.16

30-Day Relative Volume

1.26
UTHR 30-day relative volume is 1.26

Price Performance

Price Most recent change

+0.81%
UTHR price was up +0.81% on Apr 11, 2025

Price YTD change

-20.32%
UTHR price is down -20.32% since January 1st

Price 1-year change

+18.51%
UTHR price is up +18.51% year-on-year

Price 3-year change

+51.54%
UTHR price is up +51.54% over the past 3 years

Price Range

Price All-time high

$417.82
UTHR price is currently -32.71% below its historical high of $417.82

Price 3-year low

$173.22
UTHR price is currently +62.31% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$12.63B
UTHR market capitalization is $12.63 billion

Market cap 3-year change

+50.26%
UTHR market capitalization is up +50.26% over the past 3 years

Market cap All-time high

$18.28B
UTHR market capitalization is currently -30.92% below its historical high of $18.28 billion

Market cap sector rank

94.41%
UTHR market capitalization is higher than 94.41% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.6%
UTHR shares outstanding is up +1.6% year-on-year

Shares Outstanding 3-Year Change

-0.84%
UTHR shares outstanding is down -0.84% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.54
UTHR beta is 0.54

200-day SMA

$346.51
UTHR price is currently -18.86% below its 200-day simple moving average

50-day SMA

$325.55
UTHR price is currently -13.64% below its 50-day simple moving average

RSI

34.64
UTHR 14-day relative strength index is 34.64

Volume

1.26
UTHR 30-day relative volume is 1.26

ATR

$14.62
UTHR average true range is $14.62

10-day Historical Volatility

48.66%
UTHR 10-day historical volatility is 48.66%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.88B
UTHR annual revenue is $2.88 billion

Revenue Analysts estimate

$3.15B
UTHR annual revenue is currently -8.53% lower than the consensus analysts' forecast

Revenue 1-year change

+23.63%
UTHR annual revenue is up +23.63% year-on-year

Revenue Sector rank

88.13%
UTHR annual revenue is higher than 88.13% of companies in Healthcare sector

EPS

EPS

$24.64
UTHR annual earnings per share is $24.64

EPS Analysts estimate

$27.16
UTHR annual earnings per share is currently -9.29% lower than the consensus analysts' forecast

EPS 1-year change

+24.38%
UTHR annual earnings per share is up +24.38% year-on-year

EPS Sector rank

99.42%
UTHR annual earnings per share is higher than 99.42% of companies in Healthcare sector

Profit

Gross profit

$2.57B
UTHR annual gross profit is $2.57 billion

Gross margin

89.24%
UTHR annual gross profit margin is 89.24%

Operating profit

$1.45B
UTHR annual operating income is $1.45 billion

Operating margin

50.33%
UTHR annual operating profit margin is 50.33%

Net income

$1.20B
UTHR annual net profit is $1.20 billion

Net margin

41.53%
UTHR annual net profit margin is 41.53%

Expenses

Total expenses

$1.43B
UTHR annual total expenses is $1.43 billion

Operating expenses

$1.12B
UTHR annual total operating expenses is $1.12 billion

Cost of goods sold

$309.70M
UTHR annual cost of goods sold is $309.70 million

Selling, general & administrative expenses

$638.60M
UTHR annual SGA is $638.60 million

Depreciation and amortization

$72.50M
UTHR annual depreciation & amortization is $72.50 million

Interest expense

$42.90M
UTHR annual interest expense is $42.90 million

Income tax

$343.90M
UTHR annual income tax is $343.90 million

EBIT & EBITDA

EBIT

$1.58B
UTHR annual earnings before interest & taxes is $1.58 billion

EBITDA

$1.65B
UTHR annual EBITDA is $1.65 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$7.36B
UTHR annual total assets is $7.36 billion

Non current assets

$3.49B
UTHR annual long term assets is $3.49 billion

Current assets

$3.87B
UTHR annual total current assets is $3.87 billion

Cash and cash equivalents

$1.70B
UTHR annual cash & cash equivalents is $1.70 billion

Accounts receivable

$279.30M
UTHR annual accounts receivable is $279.30 million

Inventory

$157.90M
UTHR annual inventory is $157.90 million

Liabilities

Total liabilities

$920.00M
UTHR annual total liabilities is $920.00 million

Long term liabilities

$181.90M
UTHR annual total long term liabilities is $181.90 million

Current liabilities

$738.10M
UTHR annual total current liabilities is $738.10 million

Accounts payable

$6.00M
UTHR annual accounts payable is $6.00 million

Debt

Total debt

$300.00M
UTHR annual total debt is $300.00 million

Total debt 1-year change

-57.14%
UTHR annual total debt is down -57.14% year-on-year

Long term debt

-
UTHR annual long term debt value is unknown

Short term debt

$300.00M
UTHR annual short term debt is $300.00 million

Equity & Capital

Shareholders equity

$6.44B
UTHR annual stockholders equity is $6.44 billion

Book value

$6.44B
UTHR annual book value is $6.44 billion

Retained earnings

$7.22B
UTHR annual retained earnings is $7.22 billion

Working capital

$3.14B
UTHR annual working capital is $3.14 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.33B
UTHR annual cash flow from operations is $1.33 billion

Cash from operations 1-year change

+35.7%
UTHR annual cash flow from operations is up +35.7% year-on-year

Cash from investing

$417.20M
UTHR annual cash flow from investing activities is $417.20 million

Cash from investing 1-year change

+157.98%
UTHR annual cash flow from investing activities is up +157.98% year-on-year

Cash from financing

-$1.25B
UTHR annual cash flow from financing activities is -$1.25 billion

Cash from financing 1-year change

-10444.54%
UTHR annual cash flow from financing activities is down -10444.54% year-on-year

CAPEX

CAPEX

$246.50M
UTHR annual capital expenditures is $246.50 million

CAPEX 1-year change

+6.99%
UTHR annual capital expenditures is up +6.99% year-on-year

Free Cash Flow

Free cash flow

$1.08B
UTHR annual free cash flow is $1.08 billion

Free cash flow 1-year change

+44.54%
UTHR annual free cash flow is up +44.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

89.24%
UTHR annual gross profit margin is 89.24%

Operating margin

50.33%
UTHR annual operating profit margin is 50.33%

Net margin

41.53%
UTHR annual net profit margin is 41.53%

ROA & ROE

ROA

16.45%
UTHR annual return on assets is 16.45%

ROE

19.23%
UTHR annual return on equity is 19.23%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

11.43
UTHR price to earnings ratio is 11.43

PE ratio Sector rank

18.14%
UTHR price to earnings ratio is higher than 18.14% of companies in Healthcare sector

PB Ratio

PB ratio

1.96
UTHR price to book ratio is 1.96

PB ratio Sector rank

62.17%
UTHR price to book ratio is higher than 62.17% of companies in Healthcare sector

PS Ratio

PS ratio

4.39
UTHR price to sales ratio is 4.39

PS ratio Sector rank

64.23%
UTHR price to sales ratio is higher than 64.23% of companies in Healthcare sector

Enterprise value

Enterprise value

$11.23B
UTHR enterprise value is $11.23 billion

Enterprise value Sector rank

92.99%
UTHR enterprise value is higher than 92.99% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

6.79
UTHR EV/EBITDA is 6.79

EV/EBITDA Sector rank

79.43%
UTHR EV/EBITDA is higher than 79.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.25
UTHR annual current ratio is 5.25

Quick ratio

5.03
UTHR annual quick ratio is 5.03

Leverage

Debt to equity

0.05
UTHR annual debt to equity ratio is 0.05

Interest coverage ratio

36.87
UTHR annual interest coverage ratio is 36.87

Risk & Stability

Piotroski F-Score

-
UTHR piotroski f-score value is unknown

Altman Z-Score

11.22
UTHR altman z-score is 11.22

Analyst ratings

Recent major analysts updates

Feb 27, 25 HC Wainwright & Co.
Buy
Jan 8, 25 UBS
Buy
Nov 1, 24 Goldman Sachs
Neutral
Oct 31, 24 Oppenheimer
Outperform
Oct 31, 24 Ladenburg Thalmann
Buy
Oct 31, 24 HC Wainwright & Co.
Buy
Oct 31, 24 Argus Research
Buy
Oct 21, 24 TD Cowen
Buy
Sep 23, 24 Jefferies
Buy
Aug 28, 24 Oppenheimer
Outperform

Institutional Ownership

Similar stocks

COR logo
Cencora (COR)
DVA logo
DaVita (DVA)
INSM logo
Insmed Incorporated (INSM)
HOLX logo
Hologic (HOLX)
ALGN logo
Align Technology (ALGN)
GMAB logo
Genmab A/S (GMAB)
ILMN logo
Illumina (ILMN)
THC logo
Tenet Healthcare (THC)
ICLR logo
ICON Public Limited (ICLR)
  • What is the ticker symbol for United Therapeutics?
  • Does United Therapeutics pay dividends?
  • What sector is United Therapeutics in?
  • What industry is United Therapeutics in?
  • What country is United Therapeutics based in?
  • When did United Therapeutics go public?
  • Is United Therapeutics in the S&P 500?
  • Is United Therapeutics in the NASDAQ 100?
  • Is United Therapeutics in the Dow Jones?
  • When was United Therapeutics's last earnings report?
  • When does United Therapeutics report earnings?
  • Should I buy United Therapeutics stock now?

What is the ticker symbol for United Therapeutics?

The ticker symbol for United Therapeutics is NASDAQ:UTHR

Does United Therapeutics pay dividends?

No, United Therapeutics does not pay dividends

What sector is United Therapeutics in?

United Therapeutics is in the Healthcare sector

What industry is United Therapeutics in?

United Therapeutics is in the Drug Manufacturers - Specialty & Generic industry

What country is United Therapeutics based in?

United Therapeutics is headquartered in United States

When did United Therapeutics go public?

United Therapeutics's initial public offering (IPO) was on June 17, 1999

Is United Therapeutics in the S&P 500?

No, United Therapeutics is not included in the S&P 500 index

Is United Therapeutics in the NASDAQ 100?

No, United Therapeutics is not included in the NASDAQ 100 index

Is United Therapeutics in the Dow Jones?

No, United Therapeutics is not included in the Dow Jones index

When was United Therapeutics's last earnings report?

United Therapeutics's most recent earnings report was on Feb 26, 2025

When does United Therapeutics report earnings?

The next expected earnings date for United Therapeutics is May 1, 2025

Should I buy United Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page